Alan Eisenberg is Vice President, Global Public Policy & Government Relations at Alnylam. He is a corporate affairs leader who operates at the intersection of access and reimbursement, program strategy, public policy, and government relations. At Alnylam, he leads a variety of areas, including public policy and government relations, US public payer coverage, coding and reimbursement, and patient charitable foundations. He has developed and executed Alnylam strategies for access and value-based agreements with public payers as well as led government pricing and analysis.
Prior to Alnylam, Eisenberg was responsible for US Government Relations for Celgene and spent nearly a decade as Executive Vice President at the Biotechnology Innovation Organization (BIO).
Eisenberg served in a variety of senior policy making roles on Capitol Hill. He is an original author of the Average Sales Price (ASP) methodology used in Medicare Part B reimbursement and a member of teams that wrote several significant health laws, including Medicare Part D, as well as PDUFA III and pediatric exclusivity.
Eisenberg worked at Ford Motor Company in Dearborn, MI, as an economist and finance manager. Eisenberg holds master’s degrees from Harvard (Public Policy) and George Washington University (Finance), and a Bachelor of Science from Union College.